Overview
Constrictive pericarditis (CP) is a chronic condition in which the fibrous, scar‑red, or calcified pericardium (the sac that surrounds the heart) becomes stiff and thick, limiting the heart’s ability to fill with blood during diastole. This “tight‑sack” effect reduces cardiac output and leads to symptoms of heart failure, most often on the right side of the heart.
Although CP can affect anyone, it is most common in adults aged 40–70 years and slightly more prevalent in men than women. The exact worldwide prevalence is difficult to pinpoint because the disease is rare; estimates in the United States suggest an incidence of 0.5–1.0 cases per 100,000 population per year (Mayo Clinic, 2023). In developing regions where tuberculosis (TB) remains endemic, TB‑related CP accounts for up to 30‑50 % of cases, dramatically increasing local prevalence (WHO, 2022).
Symptoms
Symptoms develop gradually as the pericardium tightens. They often mimic other forms of heart failure, which can delay diagnosis.
- Shortness of breath (dyspnea) – especially on exertion or when lying flat (orthopnea).
- Fatigue and weakness – due to reduced cardiac output.
- Peripheral edema – swelling of the ankles, feet, and sometimes the abdomen (ascites).
- Abdominal fullness or bloating – from fluid accumulation.
- Chest discomfort – usually a dull ache rather than sharp pain.
- Palpitations – awareness of a rapid or irregular heartbeat.
- Weight gain – from fluid retention, not fat.
- JVD (jugular venous distention) – visible neck vein swelling, a classic sign of right‑sided heart pressure.
- Hepatomegaly – enlarged liver due to congestion, may cause right‑upper‑quadrant discomfort.
- Decreased exercise tolerance – patients tire quickly with minimal activity.
- Low‑grade fever or night sweats – sometimes present when the underlying cause is infection (e.g., TB).
Causes and Risk Factors
Constrictive pericarditis is usually the end result of chronic inflammation, infection, or injury to the pericardium. The most common etiologies differ by geography.
Common Causes
- Post‑cardiac surgery – scar formation after open‑heart procedures (≈20 % of cases in high‑income countries).
- Radiation therapy – especially for breast, lung, or lymphoma treatment.
- Tuberculosis – leading cause worldwide; mycobacterial infection triggers granulomatous inflammation.
- Idi idiopathic – no identifiable cause; thought to represent healed viral pericarditis.
- Connective‑tissue diseases – systemic lupus erythematosus, rheumatoid arthritis, scleroderma.
- Uremic pericarditis – in patients with end‑stage renal disease, especially if dialysis is delayed.
- Infectious pericarditis – bacterial, fungal, or viral infections other than TB.
- Trauma – penetrating or blunt chest injury.
Risk Factors
- History of cardiac surgery or pericardiotomy.
- Prior chest radiation (especially >30 Gy).
- Living in, or recent travel to, TB‑endemic areas.
- Autoimmune disorders (e.g., lupus, rheumatoid arthritis).
- Chronic kidney disease requiring long‑term dialysis.
- Age > 40 years and male sex (modest increased risk).
- Smoking and poor nutritional status – increase susceptibility to TB and impair healing.
Diagnosis
Because symptoms overlap with other cardiac conditions, a systematic approach is essential.
Clinical Evaluation
- Detailed medical history (surgical, radiation, infectious exposures).
- Physical exam – look for Kussmaul’s sign (increase in JVP on inspiration), pericardial knock, hepatomegaly, edema.
Imaging & Tests
- Echocardiography – first‑line. Findings include a thickened pericardium, septal “bounce,” respiratory variation in mitral/tricuspid inflow velocities, and preserved systolic function.
- Computed Tomography (CT) Scan – excellent for detecting pericardial calcification and measuring thickness (>2 mm is abnormal).
- Cardiac Magnetic Resonance (CMR) – differentiates constriction from restrictive cardiomyopathy; shows pericardial thickening, inflammation (late gadolinium enhancement), and ventricular interdependence.
- Cardiac catheterization – hemodynamic hallmark: equalization of diastolic pressures in all four chambers (within 5 mm Hg) and a “dip‑and‑plateau” (square‑root) waveform.
- Chest X‑ray – may reveal calcified pericardium or an enlarged cardiac silhouette.
- Laboratory tests – CBC, ESR/CRP (inflammation), TB PCR or interferon‑γ release assay if TB is suspected, autoimmune panels, renal function.
Diagnostic Criteria (simplified)
- Clinical signs of right‑sided heart failure and
- Imaging evidence of pericardial thickening or calcification and
- Hemodynamic confirmation of equalized diastolic pressures (or characteristic echo/CMR findings).
Treatment Options
Therapy is tailored to the underlying cause, severity of symptoms, and patient comorbidities.
Medical Management
- Diuretics (e.g., furosemide, spironolactone) – relieve volume overload and peripheral edema.
- Salt restriction – ≤2 g/day to minimize fluid retention.
- Anti‑inflammatory agents – NSAIDs or colchicine may help when active inflammation is present (e.g., post‑viral or idiopathic).
- Targeted therapy for specific causes:
- TB: standard 6‑month multidrug regimen (isoniazid, rifampin, ethambutol, pyrazinamide).
- Autoimmune: corticosteroids or disease‑modifying antirheumatic drugs (DMARDs).
- Uremia: intensified dialysis.
Surgical Intervention – Pericardiectomy
The definitive treatment for most patients with refractory constriction is subtotal or total pericardiectomy, removal of the diseased pericardium.
- Approach: median sternotomy (most common) or left anterolateral thoracotomy.
- Success rates: 70‑90 % of patients experience symptomatic relief; operative mortality ranges from 2‑8 % in experienced centers (Cleveland Clinic, 2022).
- Risk factors for poorer outcomes: very low pre‑operative ejection fraction, severe pulmonary hypertension, and concomitant myocardial disease.
Minimally Invasive Alternatives
- Video‑assisted thoracoscopic pericardiectomy – emerging technique with smaller incisions; data limited but early reports show comparable relief with shorter hospital stays.
- Pericardial window – creates a drainage opening; typically palliative for patients who are not surgical candidates.
Lifestyle & Supportive Measures
- Low‑sodium diet (<2 g Na⁺/day).
- Fluid restriction (≈1.5‑2 L/day) if instructed by a physician.
- Regular, moderate activity as tolerated – e.g., walking 15‑30 minutes most days.
- Weight monitoring: aim for stable weight; rapid gain may signal fluid accumulation.
- Vaccinations: influenza and pneumococcal vaccines to prevent respiratory infections that can exacerbate heart failure.
Living with Constrictive Pericarditis
Adapting daily life can improve quality of life and reduce hospitalizations.
Self‑Monitoring
- Check weight daily; a gain of >2 lb (≈0.9 kg) in 2–3 days warrants a call to your provider.
- Track edema – measure ankle circumference at the same time each day.
- Record symptoms (shortness of breath, fatigue) in a diary to share with your cardiologist.
Medication Adherence
Set alarms or use pill‑organizer boxes. Never stop diuretics abruptly without medical advice, as this can precipitate rapid fluid shifts.
Exercise Guidance
- Start with low‑impact activities (walking, stationary bike). Aim for “talk test” intensity – you should be able to speak in full sentences.
- Avoid heavy lifting or isometric exercises that markedly increase intrathoracic pressure.
- Consider cardiac rehabilitation programs led by a physiotherapist.
Psychosocial Support
- Join support groups (online or in‑person) for patients with chronic heart conditions.
- Seek counseling if you experience anxiety or depression; chronic disease burden is linked to mental health challenges (NIH, 2021).
Prevention
Because many cases arise from treatable underlying conditions, prevention focuses on early identification and management.
- Prompt treatment of acute pericarditis – follow anti‑inflammatory regimens and complete antibiotic courses when indicated.
- Effective TB control programs, including vaccination (BCG where used) and completion of treatment regimens.
- Minimize radiation exposure to the heart: use modern shielding techniques and limit cumulative dose.
- Control risk factors for autoimmune disease flare‑ups (stress reduction, medication compliance).
- Maintain good renal health; adhere to dialysis schedules and dietary restrictions.
Complications
If left untreated, constrictive pericarditis can lead to serious sequelae:
- Chronic right‑sided heart failure – progressive hepatic congestion, ascites, and severe edema.
- Pulmonary hypertension – due to elevated left‑sided filling pressures.
- Cardiac tamponade‑like physiology – sudden decompensation from acute fluid shifts.
- Thromboembolic events – stasis in dilated hepatic veins increases clot risk.
- Reduced exercise capacity and impaired quality of life.
- Mortality – reported 5‑year survival of 70‑80 % after successful pericardiectomy, but <10‑20 % in untreated severe cases (Mayo Clinic, 2022).
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you develop any of the following:
- Sudden, severe shortness of breath not relieved by resting.
- Rapid, pounding heartbeat (tachycardia > 120 bpm) with chest pain.
- New or worsening swelling of the abdomen accompanied by pain.
- Fainting or near‑fainting spells.
- Sudden onset of bluish lips or fingertips (cyanosis).
- Severe, uncontrolled leg swelling that develops within a few hours.
References
- Mayo Clinic. Constrictive Pericarditis. Updated 2023. https://www.mayoclinic.org
- World Health Organization. Global Tuberculosis Report 2022. WHO; 2022.
- Cleveland Clinic. Pericardiectomy for Constrictive Pericarditis: Outcomes and Risks. 2022.
- National Institutes of Health. Heart Failure Management Guidelines. 2021.
- American Heart Association. 2024 Guideline for the Management of Pericardial Diseases.
- CDC. Tuberculosis (TB) – Treatment and Prevention. 2023.